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1. Introduction
   The viral disease is usually the problem in medicine. The 
new emerging disease has been continuously reported in 
the past decade. Several new infections occur and become 
the great concern of the medical society. The 2014 West 
Africa Ebola outbreak is an ongoing epidemic of the Ebola 
virus disease in West Africa[1]. The outbreak began in the 
Republic of Guinea in February of 2014. Since its initial 
outbreak, the virus has already spread to the Republic 
of Liberia and the Republic of Sierra Leone[1-5]. The 2014 
West Africa Ebola outbreak is believed to be the most 
severe in recorded medical history in regards to both the 
number of human cases and fatalities. A suspected 1 440 
cases with 826 deaths have been reported by the World 
Health Organization (WHO) as of 30 July 2014 (currently only 
953 cases and 532 deaths have been laboratory confirmed 
to be Ebola)[6]. This disease might be one of the serious 
problems in the world history. Wiwanitkit noted that there 
are three main problems of the emerging 2014 West Africa 
Ebola at present: a) occurrence in urban area, b) no effective 
diagnostic tool and treatment and c) no vaccine[1]. Enserink 
noted in Science that “Ebola drugs still stuck in lab[3]” and 
this might be slower than the spreading potential of disease. 
With those problems, the 2014 West Africa Ebola is still the 
great danger and the medical personnels have to update 
knowledge of this emerging disease. WHO calls for global 
concern and attempts to stop the spread of this emerging 
viral infection. Crisis talks have been continuously done by 
health ministers in West Africa[7]. In this brief review, the 
author presents and discusses on the clinical feature of the 
new emerging West Africa Ebola 2014.
2. Brief information on classical Ebola
   The classical Ebola has been first detected for a long 
time. Historically, in mid-1976, new disease outbreaks 
were seen in Sudan and Zaire[8,9]. The patients had a high 
fever, headache keypad or motorboats, blurred vision and 
vomiting then there would be rashes on the body later. 
Bleeding under the skin and bleeding from internal organs, 
including liver, kidney, stomach and intestinal were also 
observed. Those hemorrhagic problems had the effect of 
a shock. The patient died in a short time from onset of 
symptoms (until death, it usually took 4-10 d). Finally, the 
cause of this outbreak was successfully detected and the 
new virus was identified and this is the first appearance of 
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Ebola virus in the world[8,9].
   Virologically[8,9], Ebola virus is in family Filoviridae, 
which has: a) the RNA genome into a single, clear and has a 
length of 12.7 kb, molecular weight 4.2伊10-6, no poly(A) at the 
3 ‘viral particles contain proteins, b) 7 enzymes including 
transcriptase, which act on creating a sequence-mRNA, c) 
nucleocapsid spiral staircase (helical) with a diameter of 
80 nm and length 800-1 000 nm, enclosed membrane lipids 
(envelope) with a stem extending peplomer and d) shaped 
in many ways including long lines or circular-shaped 
contours. The virus can be destroyed by lipid solvents/UV/
gamma/formaldehyde 1%/beta-pro oak lactone/acetic 3%/
a compound disinfectant phenolic/matrix hypochlorite 
chloride. At room temperature, the virus can trigger 
infections in several days, but will be destroyed at 60 °C in 
a 30-minutes period. There are 2 subtypes of Ebola virus 
including Sudan subtype (Ebola-S) and Zaire subtype 
(Ebola-Z). The virus can cause an infection in multiple 
organ systems (pantropic), but the most common affected 
organs are liver and spleen, where the virus is to stop for 
development and increase in number.
   A 2-21 days incubation period is noted. After incubation, 
a viral-like illness will develop. A fatal syndrome will 
occur. Martínez and Ramírez Ronda noted that “as days 
go by, symptoms worsen, and by the 7th day, a severe and 
diffuse bleeding tendency ensues[10]” and “the individual’s 
death is the most likely outcome in the great majority of 
cases[10].” To diagnose Ebola virus, which is a deadly serious 
pathogens, WHO mentions for the requirement of bio-safety 
level 4 medical laboratory. Definitive diagnosis can be by 
antigen detection in tissues from various organs. Using 
specific antibodies from immune fluorescence staining 
method can also be an alternative technique[11]. Detection 
of the genome of the virus by RT-PCR or detection of viral 
particles by electron microscopy are the reference diagnostic 
techniques[11].
   The interesting question is why the disease is too 
serious. The main clinical features of the disease that 
lead to high mortality include: a) the virus firstly and 
mainly attack lymphoid organ as spleen and this result in 
immunodeficiency state and b) the virus attach vascular 
system, as a pattern of viral hemorrhagic disease.
3. The 2014 West Africa Ebola outbreak
   As noted, the 2014 West Africa Ebola outbreak is of 
concern at present. This disease becomes a big news when 
its rapidly expands in Africa and the medical personnels 
get infected and result in death[12-14]. Changula et al. 
noted that “there has been an increase in the incidence 
of filovirus hemorrhagic fever outbreaks in Africa in the 
last two decades, with some caused by a newly found virus 
and some occurring in previously unaffected areas such as 
Guinea, Liberia and Sierra Leone, which suffered the most 
recent Ebola virus disease outbreak in 2014[13].” Dixon et al. 
concluded the present situation that “On March 21, 2014, the 
Guinea Ministry of Health reported the outbreak of an illness 
characterized by fever, severe diarrhea, vomiting, and a high 
case-fatality rate (59%) among 49 persons[15]. Specimens from 
15 of 20 persons tested at Institut Pasteur in Lyon, France, 
were positive for an Ebola virus by PCR[15].” Guinea, Liberia 
and Sierra Leone are already affected. “An outlier strain of 
Zaire subtype Ebola virus” is identified as the problematic 
pathogen for the present 2014 West Africa Ebola outbreak. 
Gatherer noted that “the full geographical extent and degree 
of severity of the outbreak, its zoonotic origins and its 
possible spread to other continents are sure to be subjects 
of intensive discussion over the next months[16].” The great 
concern on the newly detected mutated virus is its property. 
The present question includes whether it will be the new 
virus that can be air-borne transmitted. If the answer is yes, 
we are facing the actual greatest outbreak in the medical 
history since it combined the severity as hemorrhagic 
disease, immunosuppression as immunodeficiency virus 
and contagiousness as air-borne disease (like combining 
hemorrhagic fever with AIDS with new emerging influenza).
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